Senior Manager, IT Technical Security
Cytokinetics
Summary
Cytokinetics continues to mature its Cybersecurity Program including its policies, procedures, controls, guidelines, and technologies. This role is responsible for performing the day-to-day oversight, implementation, and operations of technical platforms that support the broader Cybersecurity Program.
Job description
This individual should have a firm understanding of key technologies and features (e.g., authentication and access management platforms, multi-factor authentication technologies, end-point detection and remediation tools, OS and application hardening, cloud computing infrastructures, vulnerability and patch management, etc.).
Responsibilities
- Monitor the security posture of enterprise technology environments across cloud and on-premises infrastructure, endpoints, networks, identity platforms, and business applications.
- Maintain a structured process for aggregating, analyzing, and tracking vulnerability data to identify trends, prioritize risks, monitor remediation progress, and support informed decision-making.
- Collaborate with internal stakeholders and external partners to assess, prioritize, and remediate security issues using a risk-based approach that balances business needs, operational impact, and security requirements.
- Review critical infrastructure platform configurations (e.g., Exchange, SharePoint, Teams, Box, Azure, and AWS, Firewalls) and work with internal and external support teams to harden in accordance with current security requirements and standards.
- Maintain a technical security scorecard and report to CISO and IT on a periodic basis.
- Own and coordinate the investigation and response to cybersecurity events and incidents, including triage, containment, remediation, recovery, and follow-up.
Qualifications
- 8+ years of relevant IT or cybersecurity experience, including 5+ years implementing and managing enterprise security platforms; a bachelor's degree in a related field or equivalent practical experience is preferred.
- Must have firm understanding of NIST framework and supporting procedures and controls.
- Strong verbal and written communication including presentation of complex information to the broad company in an easy and consumable format.
- Must have strong collaboration skills.
- Must be highly organized and curious.
- Be a highly collaborative team member with other IT as well as business colleagues to drive down security risk balanced with appropriate risk acceptance and soft-touch education as necessary.
Requirements
- 8+ years of relevant IT or cybersecurity experience
- 5+ years implementing and managing enterprise security platforms
- Bachelor's degree in a related field or equivalent practical experience (preferred)
- Firm understanding of NIST framework and supporting procedures and controls
- Strong verbal and written communication
- Strong collaboration skills
- Highly organized and curious
Benefits
- Stock Options
- Restricted Stock Units
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- 401(k) With Employer Match
- Learning Stipends
- Wellness Stipends
- Paid Time Off
Company overview
Cytokinetics, Incorporated is a late-stage biopharmaceutical company headquartered in South San Francisco, California, specializing in muscle biology research and drug development. Founded in 1997 by leading scientists from Stanford, UCSD, and UCSF, the company focuses on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors for debilitating diseases characterized by impaired or declining muscle function. With over 25 years of scientific expertise, Cytokinetics has built a robust pipeline targeting cardiovascular and neuromuscular conditions including heart failure, hypertrophic cardiomyopathy, and amyotrophic lateral sclerosis (ALS). The company's innovative approach centers on directly targeting the sarcomere, the fundamental unit of muscle contraction, to develop potential treatments that may preserve and extend independence for patients. Cytokinetics operates as a publicly traded company (NASDAQ: CYTK) and has established itself as a leader in muscle biology with more than 115 publications, over 100 clinical trials, and hundreds of issued patents.